The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“Lifestyle changes are the first-line treatment in the prevention of diabetes [38, 39, 40].”
BackgroundPearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401 · cited 7×
“We used only CRP as a marker of inflammation, with cut-off values as recommended by the Centers for Disease Control and the American Heart Association [6].”
BackgroundMethodInfluentialInflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884 · cited 1×
“In a small study, high-dose aspirin has been shown to improve glucose tolerance and insulin sensitivity in patients with Type 2 diabetes [35], presumably by inhibiting the serine kinase, IKKβ [36].”
BackgroundInflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Esposito, K., Pontillo, A., Di Palo, C., Giugliano, G., Masella, M., Marfella, R., & Giugliano, D. (2003) · JAMA · doi:10.1001/jama.289.14.1799 · Cited by 1,511 · cited 1×
“Weight loss [32] and weight loss combined with physical activity and dietary changes [41, 42] have been shown to decrease markers of inflammation in obese individuals, including those with features of the metabolic syndrome [42].”
BackgroundInflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
(1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.6.1071 · Cited by 1,137
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
C-Reactive Protein and the Risk of Developing Hypertension
Sesso, H. D. (2003) · JAMA · doi:10.1001/jama.290.22.2945 · Cited by 1,004
Laaksonen, D. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf145 · Cited by 916 · cited 2×
“The WHO definition of the metabolic syndrome was modified as described previously [23, 24] and defined as the presence of hyperinsulinaemia (fasting serum insulin concentration in the top 25% of values for non-diabetic men), impaired fasting glucose or diabetes, and the presence of at least two of the following: (i) a…”
MethodSelf-citationInsulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Fernández-Real, J. M., & Ricart, W. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0010 · Cited by 886
Lakka, T. A., Venalainen, J. M., Rauramaa, R., Salonen, R., Tuomilehto, J., & Salonen, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406023302201 · Cited by 793 · cited 1×
“Assessments of medical history and medications, smoking, alcohol intake, socioeconomic status and moderate-to-vigorous physical activity have been described previously [28, 29, 30].”
BackgroundSelf-citationFreeman, D. J., Norrie, J., Caslake, M. J., Gaw, A., Ford, I., Lowe, G. D. O., O’Reilly, D. S. J., Packard, C. J., Sattar, N., & for the West of Scotland Coronary Prevention Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1596 · Cited by 728
Laaksonen, D. E., Lakka, H.-M., Salonen, J. T., Niskanen, L. K., Rauramaa, R., & Lakka, T. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.9.1612 · Cited by 657 · cited 1×
“Assessments of medical history and medications, smoking, alcohol intake, socioeconomic status and moderate-to-vigorous physical activity have been described previously [28, 29, 30].”
BackgroundSelf-citationMechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S. E., Shoelson, S. E., & Shulman, G. I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14955 · Cited by 621
Senn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., & Mooney, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210689200 · Cited by 620 · cited 2×
“In vitro and small human studies have suggested several mechanisms by which low-grade inflammation may increase insulin resistance, dyslipidaemia, and endothelial dysfunction [1, 2, 3, 4, 5, 15, 16, 17].”
BackgroundLiu, S., Manson, J. E., Buring, J. E., Stampfer, M. J., Willett, W. C., & Ridker, P. M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.3.492 · Cited by 594
Pischon, T., Hankinson, S. E., Hotamisligil, G. S., Rifai, N., Willett, W. C., & Rimm, E. B. (2003) · Circulation · doi:10.1161/01.cir.0000079224.46084.c2 · Cited by 560
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S., Shoelson, S. E., & Shulman, G. I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214955 · Cited by 557
Han, T. S., Sattar, N., Williams, K., Gonzalez-Villalpando, C., Lean, M. E. J., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2016 · Cited by 513
Sedentary Lifestyle, Poor Cardiorespiratory Fitness, and the Metabolic Syndrome
LAKKA, T. A., LAAKSONEN, D. E., LAKKA, H.-M., M??NNIKK??, N., NISKANEN, L. K., RAURAMAA, R., & SALONEN, J. T. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000079076.74931.9a · Cited by 472
Self-citationSex hormones, inflammation and the metabolic syndrome: a population-based study
Laaksonen, D., Niskanen, L., Punnonen, K., Nyyssonen, K., Tuomainen, T., Salonen, R., Rauramaa, R., & Salonen, J. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490601 · Cited by 438
Self-citationC-reactive protein and the risk of developing hypertension
Sesso, H. D., Buring, J. E., Rifai, N., Blake, G. J., Gaziano, J. M., & Ridker, R. M. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.02.025 · Cited by 430
Kopp, H. P., Kopp, C. W., Festa, A., Krzyzanowska, K., Kriwanek, S., Minar, E., Roka, R., & Schernthaner, G. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000073313.16135.21 · Cited by 427 · cited 2×
“Weight loss [32] and weight loss combined with physical activity and dietary changes [41, 42] have been shown to decrease markers of inflammation in obese individuals, including those with features of the metabolic syndrome [42].”
BackgroundAssociations Between Cardiorespiratory Fitness and C-Reactive Protein in Men
Church, T. S., Barlow, C. E., Earnest, C. P., Kampert, J. B., Priest, E. L., & Blair, S. N. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000036611.77940.f8 · Cited by 382
Reduction in the Incidence of Type 2 Diabetes With Lifestyle Intervention or Metformin
(2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000055759.75837.e7 · Cited by 377
Thorand, B., Löwel, H., Schneider, A., Kolb, H., Meisinger, C., Fröhlich, M., & Koenig, W. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.93 · Cited by 368
SALONEN, J. T. (1988) · PubMed · Cited by 347
Self-citationChildhood and adult socioeconomic status as predictors of mortality in Finland
Lynch, J. W., Kaplan, G. A., Cohen, R. D., Wilson, T. W., Smith, N. L., Kauhanen, J., & Salonen, J. T. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91468-0 · Cited by 303
Self-citationFesta, A., Hanley, A. J. G., Tracy, R. P., D’Agostino, R., & Haffner, S. M. (2003) · Circulation · doi:10.1161/01.cir.0000091339.70120.53 · Cited by 232
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
(1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370524 · Cited by 230
Do atherosclerosis and type 2 diabetes share a common inflammatory basis?
Pradhan, A. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3052 · Cited by 214
Rask-Madsen, C., Domínguez, H., Ihlemann, N., Hermann, T., Køber, L., & Torp-Pedersen, C. (2003) · Circulation · doi:10.1161/01.cir.0000091406.72832.11 · Cited by 177
Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168
Duncan, B. B., Schmidt, M. I., Chambless, L. E., Folsom, A. R., Carpenter, M. A., HEISS, G. M., & for the ARIC Investigators (2000) · Obesity Research · doi:10.1038/oby.2000.33 · Cited by 167
Nakanishi, S., Yamane, K., Kamei, N., Okubo, M., & Kohno, N. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2754 · Cited by 161
Epidemiology and treatment of the metabolic syndrome
Laaksonen, D. E., NISKANEN, L. K., Lakka, H., Lakka, T. A., & Uusitupa, M. I. J. (2004) · Annals of Medicine · doi:10.1080/07853890410031849 · Cited by 144
Self-citationC-reactive protein and atherothrombosis—Beyond a biomarker: an actual partaker of lesion formation
Verma, S., & Yeh, E. T. H. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00170.2003 · Cited by 131
Fernández‐Real, J. M., PUGEAT, M. M., Grasa, M., Broch, M., Vendrell, J. J., Brun, J., & Ricart, W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011843 · Cited by 118
Tan, K. C. B., Wat, N. M. S., Tam, S., Janus, E. D., Lam, T., & Lam, K. S. L. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2323 · Cited by 87
Plutzky, J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00614-3 · Cited by 82
C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?
Blake, G. J., & Ridker, P. M. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00227.2003 · Cited by 47
Crook, M. A., Scott, D. A., Stapleton, J., Palmer, R. M. J., Wilson, R. F., & Sutherland, G. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00738.x · Cited by 43
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Metadata
- Authors
- Laaksonen, D. E., Niskanen, L., Nyyss�nen, K., Punnonen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T.
- Venue
- Diabetologia
- Published
- 2004-07-28
- Volume
- 47
- Issue
- 8
- Pages
- 1403-10
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1970643505
- Cited by
- 289
- References
- 56
- FWCI
- 13.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.